Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 74459.53 308.49 (0.42%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
61	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	5,741 Small Cap	176.90 (-3.47%)	3.62	4.36	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Innova Captab Ltd.	Q V PT	5,900 Small Cap	1,031.10 (-1.87%)	37.75	5.2	31.75	26.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	FDC Ltd.	Q V PT	6,132 Small Cap	376.65 (-0.13%)	19.53	2.29	9.91	0.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Nephrocare Health Services Ltd.	Q V PT	6,194 Small Cap	615.95 (-2.28%)	80.61	5.46	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	Morepen Laboratories Ltd.	Q V+ PT	6,230 Small Cap	113.70 (-4.97%)	33.04	4.51	8.73	-11.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Kovai Medical Center & Hospital Ltd.	Q V PT	6,356 Small Cap	5,808.45 (-1.45%)	24.8	4.58	18.09	25.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Supriya Lifescience Ltd.	Q V+ PT	6,810 Small Cap	846.20 (-2.56%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Bliss GVS Pharma Ltd.	Q V+ PT	6,898 Small Cap	648.40 (-5.00%)	42.79	5.34	9.94	8.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Thyrocare Technologies Ltd.	Q V PT	7,274 Small Cap	457 (-11.30%)	50.44	13.14	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	Suven Life Sciences Ltd.	Q V+ PT	7,293 Small Cap	258.10 (-2.53%)	N/A	13.1	-12.01	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Sanofi India Ltd.	Q V PT	7,380 Small Cap	3,204.40 (0.46%)	17.86	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	7,911 Small Cap	3,435.05 (-0.95%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Aarti Pharmalabs Ltd.	Q V+ PT	7,922 Small Cap	873.65 (-5.81%)	32.61	3.77	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Jupiter Life Line Hospitals Ltd.	Q V PT	8,402 Small Cap	256.30 (-1.69%)	45.07	5.15	25.27	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Healthcare Global Enterprises Ltd.	Q V+ PT	8,731 Small Cap	584.80 (-1.09%)	522.51	5.42	17.43	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Yatharth Hospital & Trauma Care Services Ltd.	Q V PT	8,942 Small Cap	928.05 (0.62%)	49.36	4.9	39.48	45.83	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	Procter & Gamble Health Ltd.	Q V PT	9,436 Small Cap	5,684.40 (3.15%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Park Medi World Ltd.	Q V PT	9,513 Small Cap	220.25 (-0.47%)	36.86	4.53	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	Blue Jet Healthcare Ltd.	Q V PT	9,547 Small Cap	504.40 (0.11%)	40.64	4.27	13.68	9.45	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Viyash Scientific Ltd.	Q V PT	9,653 Small Cap	218.50 (-2.82%)	56.39	3.43	20.23	2.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	Strides Pharma Science Ltd.	Q V+ PT	9,855 Small Cap	1,069.15 (-2.57%)	15.98	2.88	7.94	21.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Metropolis Healthcare Ltd.	Q V PT	11,310 Small Cap	545.15 (-1.60%)	56.09	7.25	10.52	0.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	Akums Drugs & Pharmaceuticals Ltd.	Q V PT	11,520 Small Cap	731.90 (-1.24%)	39.49	3.37	9.87	8.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	Rainbow Childrens Medicare Ltd.	Q V PT	12,366 Small Cap	1,217.55 (1.63%)	42.32	7.21	21.24	43.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Concord Biotech Ltd.	Q V PT	13,028 Small Cap	1,245.30 (1.25%)	46.12	6.28	11.33	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	CORONA Remedies Ltd.	Q V+ PT	13,125 Small Cap	2,146.05 (-3.12%)	63.4	16.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Marksans Pharma Ltd.	Q V+ PT	13,896 Small Cap	306.65 (-2.68%)	26.89	4.37	16.48	7.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Indegene Ltd.	Q V+ PT	14,164 Small Cap	587.65 (-1.07%)	34.45	4.22	29.44	13.80	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	Poly Medicure Ltd.	Q V PT	14,676 Small Cap	1,447.90 (-1.03%)	46.58	4.61	18.98	16.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Jubilant Pharmova Ltd.	Q V+ PT	14,729 Small Cap	924.70 (-1.88%)	41.83	2.07	6.31	-7.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anuh Pharma	87.09	8.86%
Laurus Labs	2,392	6.55%
SMS Pharmaceuticals	511.75	5.33%
Wanbury	189.75	5.10%
Zydus Lifesciences	1,244	4.89%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
RPG Life Sciences	2,572.40	-14.13%
Thyrocare Tech.	457	-11.30%
Gennex Laboratories	8.02	-10.49%
Ind-Swift Labs.	367.40	-10.14%
Cohance Lifesciences	444.45	-7.67%

News about Top Pharma Companies in India

Nov, 2026

RainbowChildrenS Med - Quaterly Results

A fair growth of 19.22% in the revenue at Rs. 4869.91 millions was reported in the September 2026 quarter as compared to Rs. 4084.96 millions during year-ago period.A meek growth of 2.63% was reported for the quarter ended September 2026 to Rs. 750.93 millions from Rs. 731.67 millions.Operating Profit saw a handsome growth to 1595.88 millions from 1488.91 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	4869.91	4084.96	19.22	8975.38	7432.44	20.76	15456.60	14545.06	6.27
Other Income	80.92	81.73	-0.99	208.49	274.58	-24.07	434.54	489.49	-11.23
PBIDT	1595.88	1488.91	7.18	2870.04	2676.97	7.21	5433.11	5234.23	3.80
Interest	199.14	173.09	15.05	391.63	347.02	12.86	713.96	695.94	2.59
PBDT	1396.74	1315.82	6.15	2478.41	2329.95	6.37	4703.76	4538.29	3.65
Depreciation	398.09	331.82	19.97	774.35	657.75	17.73	1362.61	1317.48	3.43
PBT	998.65	984.00	1.49	1704.06	1672.20	1.91	3341.15	3220.81	3.74
TAX	247.72	252.33	-1.83	426.07	423.33	0.65	840.99	844.98	-0.47
Deferred Tax	-57.47	-27.87	106.21	-68.71	-22.06	211.47	-73.38	-31.54	132.66
PAT	750.93	731.67	2.63	1277.99	1248.87	2.33	2500.16	2375.83	5.23
Equity	1015.66	1015.59	0.01	1015.66	1015.59	0.01	1015.59	1015.52	0.01
PBIDTM(%)	32.77	36.45	-10.09	31.98	36.02	-11.22	35.15	35.99	-2.32

Oct, 2026

Corona Remedies informs about newspaper publication

Corona Remedies has informed that the Board of Directors, at its meeting held on Friday, October 30, 2026 had considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the second quarter and half year ended on September 30, 2026. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, they are enclosed the newspaper advertisement of the Unaudited Financial Results, published today in Financial Express (English and Gujarati). The extract of aforesaid newspaper publication is also being made available on the website of the Company at www.coronaremedies.com

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Indegene informs about newspaper advertisement

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indegene has informed that it enclosed copies of the newspaper advertisement published in Financial Express (English) and Vishwavani (Kannada) today, relating to financial results for 2nd quarter and half year ended September 30, 2026. The above information will be made available on the website of the Company: https://www.indegene.com/.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Strides Pharma Science informs about analyst meet outcome

Pursuant to Regulations 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Strides Pharma Science has informed that the audio recording of the Earnings Call held for investors and analysts today, Friday, October 30, 2026, at 10:00 hrs IST, to discuss Company’s unaudited financial results for the quarter and half year ended September 30, 2026, has been made available on the Company’s website at: https://www.strides.com/investors/financial-performance/quarterly-results

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Kovai Medical Center & Hospital informs about updates

Kovai Medical Center & Hospital has informed that it enclosed the details of Adjudication order received by the Company from the Joint Commissioner of Customs, Office of the Principal Commissioner of Customs (Air Cargo),Chennai.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Sanofi India - Quaterly Results

The quarter ended September 2026 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 4917.00 millions.The Profit for the quarter ended September 2026 of Rs. 1167.00 millions grew by 53.55% from Rs. 760.00 millions.Operating profit for the quarter ended September 2026 rose to 1667.00 millions as compared to 1391.00 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202512	202412	% Var
Sales	4917.00	4754.00	3.43	14017.00	14176.00	-1.12	18374.00	20132.00	-8.73
Other Income	55.00	49.00	12.24	161.00	169.00	-4.73	197.00	165.00	19.39
PBIDT	1667.00	1391.00	19.84	4354.00	4179.00	4.19	5110.00	5073.00	0.73
Interest	2.00	4.00	-50.00	8.00	11.00	-27.27	17.00	15.00	13.33
PBDT	1665.00	1114.00	49.46	4346.00	3895.00	11.58	4820.00	4681.00	2.97
Depreciation	88.00	91.00	-3.30	267.00	278.00	-3.96	373.00	367.00	1.63
PBT	1577.00	1023.00	54.15	4079.00	3617.00	12.77	4447.00	4314.00	3.08
TAX	410.00	263.00	55.89	1051.00	967.00	8.69	1180.00	1177.00	0.25
Deferred Tax	3.00	-49.00	-106.12	4.00	-52.00	-107.69	-49.00	-81.00	-39.51
PAT	1167.00	760.00	53.55	3028.00	2650.00	14.26	3267.00	3137.00	4.14
Equity	230.00	230.00	0.00	230.00	230.00	0.00	230.00	230.00	0.00
PBIDTM(%)	33.90	29.26	15.87	31.06	29.48	5.37	27.81	25.20	10.37

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Medico Remedies Ltd.	155 Crore
2	Take Ltd.	159 Crore
3	Gennex Laboratories Ltd.	195 Crore
4	Ambalal Sarabhai Enterprises Ltd.	268 Crore
5	Medicamen Biotech Ltd.	359 Crore
6	Fabtech Technologies Ltd.	547 Crore
7	Wanbury Ltd.	664 Crore
8	Kilitch Drugs (India) Ltd.	703 Crore
9	Gaudium IVF and Women Health Ltd.	770 Crore
10	One Global Service Provider Ltd.	854 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,635	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,392	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,678	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,928	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,489	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,244	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,350	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

RainbowChildrenS Med - Quaterly Results

Corona Remedies informs about newspaper publication

Indegene informs about newspaper advertisement

Strides Pharma Science informs about analyst meet outcome

Kovai Medical Center & Hospital informs about updates

Sanofi India - Quaterly Results

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?